{
    "title": "U.S. FDA panel backs female libido drug, with conditions",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3111570/U-S-FDA-panel-supports-female-libido-drug-risk-management-plan.html",
    "date": "2015-06-04",
    "keywords": [
        "drug",
        "fda",
        "panel",
        "june",
        "desire",
        "flibanserin",
        "risk",
        "gmt",
        "sprout",
        "approval",
        "management",
        "injury",
        "bremelanotide",
        "dysfunction",
        "trade",
        "market",
        "viagra",
        "email",
        "clarkewashington",
        "place",
        "food",
        "administration",
        "thursdayif",
        "program",
        "none",
        "product",
        "programthe",
        "blood",
        "pressurepalatin",
        "percent",
        "palatin",
        "billionthe",
        "recommendation",
        "lobbying",
        "number",
        "advocacy",
        "gender",
        "bias",
        "agency",
        "campaign",
        "attempt",
        "concern",
        "car",
        "deathboth",
        "work",
        "brain",
        "flow",
        "distress",
        "name",
        "advice",
        "pill",
        "injection",
        "stage",
        "half",
        "campaignalcohol",
        "use",
        "label",
        "box",
        "alcoholflibanserin",
        "antidepressant",
        "boehringer",
        "ingelheim",
        "meeting",
        "baseline",
        "month",
        "placebo",
        "effect",
        "increase",
        "establishment",
        "registry",
        "safety",
        "reporting",
        "clarke",
        "editing",
        "maler",
        "david",
        "gregorio"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}